MedTrace Logo

Optimization of MRI Sequences Used in the Study of Neurodegenerative Diseases

NCT05929144 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-07-03

No results posted yet for this study

Summary

The Inserm NeuroPresage team has been using MRI for more than 20 years in the study of normal ageing and memory pathologies to further the understanding and the characterization of early diagnosis and the cerebral substrates of cognitive deficits in patients, particularly in the context of neurodegenerative diseases.

Two years ago, a new 3T MRI camera was installed at the Cyceron centre. It is more efficient and should make it possible to obtain better quality images and/or to reduce the time required to acquire these images.

In this context, it seems important to test the different sequences that we classically use in our studies, or that we plan to implement in our next studies (learning and text retrieval fMRI task), in order to optimize them, with a view to integrating them in our future studies.

Conditions

  • Memory Disorders

Interventions

OTHER

MRI sequences testing

Testing different MRI sequences in order to optimize them

Sponsors & Collaborators

  • University Hospital, Caen

    lead OTHER

Principal Investigators

  • Gaël Chételat, PhD · Institut National de la Santé Et de la Recherche Médicale, France

  • Nicolas Cabé, MD, PhD · CHU Caen Normandie

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-05
Primary Completion
2028-07-31
Completion
2028-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05929144 on ClinicalTrials.gov